Application of the ESMO-Magnitude of Clinical Benefit Scale (V.1.1) to the field of early breast cancer therapies.

Paluch-Shimon, Shani; Cherny, Nathan I; de Vries, Elisabeth G E; Dafni, Urania; Piccart, Martine J; Latino, Nicola Jane; Cardoso, Fatima

Paluch-Shimon, Shani; Cherny, Nathan I; de Vries, Elisabeth G E; Dafni, Urania; Piccart, Martine J; Latino, Nicola Jane; Cardoso, Fatima.

Afiliação

Paluch-Shimon S; Oncology, Shaare Zedek Medical Center, Jerusalem, Israel. Electronic address: shani.paluch@gmail.com.
Cherny NI; Oncology, Shaare Zedek Medical Center, Jerusalem, Israel.
de Vries EGE; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Dafni U; National and Kapodistrian University of Athens, Athens, Greece; Frontier Science Foundation-Hellas, Athens, Greece.
Piccart MJ; Université Libre de Bruxelles, Institut Jules Bordet, Bruxelles, Belgium.
Latino NJ; ESMO-MCBS Working Group, European Society for Medical Oncology, Viganello, Switzerland.
Cardoso F; Breast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Lisbon, Portugal.

ESMO Open ; 5(5): e000743, 2020 09.

Article em En | MEDLINE | ID: mdl-32893189

Assuntos

Neoplasias da Mama; Neoplasias da Mama/tratamento farmacológico; Feminino; Humanos; Oncologia; Intervalo Livre de Progressão

Palavras-chave

ESMO-MCBS; early breast cancer; magnitude of clinical benefit scale

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama Idioma: En Ano de publicação: 2020 Tipo de documento: Article